多中心前瞻性胰腺炎流行病学与转化研究(PROCEED)显示:血清免疫谱差异界定急性和慢性胰腺炎谱系
基于PROCEED研究231例受试者(无胰腺疾病56例、慢性腹痛24例、急性胰腺炎38例、复发性急性胰腺炎56例、慢性胰腺炎57例)的血清Olink免疫检测,33种免疫标志物可区分胰腺炎组与对照组;IL17信号相关标志物区分慢性胰腺炎与急性/复发性急性胰腺炎,IL17A与SSTA1A1联合区分慢性胰腺炎与慢性腹痛的乐观AUC为0.78。
要点
- 33种免疫标志物可区分胰腺炎组与对照组。
- IL17信号相关标志物区分慢性胰腺炎与急性及复发性急性胰腺炎。
- IL17A与SSTA1A1联合区分慢性胰腺炎与慢性腹痛的乐观AUC为0.78。
核心结论
- 血清免疫谱分析识别出可区分不同胰腺炎疾病状态的潜在生物标志物。
- 慢性胰腺炎中IL17信号的发现可能有助于理解疾病进展的免疫机制。
研究设计与样本
- 研究为PROCEED多中心前瞻性队列研究,纳入231例受试者。
- 采用Olink免疫检测法测定血清中92种免疫标志物的蛋白水平。
主要发现
- 33种免疫标志物可区分合并胰腺炎组与对照组。
- IL17信号相关免疫标志物区分慢性胰腺炎与急性胰腺炎及复发性急性胰腺炎。
- 血清IL17A和CCL20水平区分慢性胰腺炎与慢性腹痛,提示Th17细胞参与慢性胰腺炎发病。
- IL17A和SSTA1A1两种免疫标志物的ROC曲线区分慢性胰腺炎与慢性腹痛的乐观AUC为0.78。
- 巨噬细胞经典激活通路沿胰腺炎连续谱升高,提示疾病进展中促炎信号累积。
关键数值与推荐
- 样本包括无胰腺疾病56例、慢性腹痛24例、急性胰腺炎38例、复发性急性胰腺炎56例、慢性胰腺炎57例。
- 部分免疫标志物与吸烟、酒精及糖尿病状态相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Pancreatitis is a disease continuum, starting with acute pancreatitis (AP) and progressing in some cases to recurrent acute pancreatitis (RAP) and chronic pancreatitis (CP). Currently, there are no approved therapies or early diagnostic or prognostic biomarkers for pancreatitis. The current study examined whether patient serum immune profiling could identify noninvasive biomarkers and provide mechanistic insight into the disease continuum of pancreatitis. METHODS: Using Olink immunoassay, we assessed the protein levels of 92 immune markers in serum samples from participants enrolled in the Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) study of the Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) consortium. Samples (N = 231) were obtained from individuals without pancreatic disease (n = 56) and from those with chronic abdominal pain (CAP) (n = 24), AP (n = 38), RAP (n = 56), and CP (n = 57). RESULTS: A total of 33 immune markers differentiated the combined pancreatitis groups from controls. Immune markers related to interleukin (IL) 17 signaling distinguished CP from AP and RAP. Similarly, the serum level of IL17A and C-C motif chemokine ligand 20 differentiated CP from CAP, suggesting the involvement of T helper 17 cells in CP pathogenesis. The receiver operator characteristic curve with 2 immune markers (IL17A and sulfotransferase 1A1) could differentiate CP from CAP (optimistic area under the curve = 0.78). The macrophage classical activation pathway elevated along the continuum of pancreatitis, suggesting an accumulation of proinflammatory signals over disease progression. Several immune markers were associated with smoking, alcohol, and diabetes status. CONCLUSIONS: Immune profiling of serum samples from a large pancreatitis cohort led to identifying distinct immune markers that could serve as potential biomarkers to differentiate the varying pancreatitis disease states. In addition, the finding of IL17 signaling in CP could provide insight into the immune mechanisms underlying disease progression.
引用
- Lee B, Jones EK, Manohar M, et al. Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study. Gastroenterology. 2023. PMID: 37061168. doi:10.1053/j.gastro.2023.03.236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。